5//SEC Filing
Schatzman Randall C 5
Accession 0001209191-23-007575
CIK 0001641281other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:53 PM ET
Size
6.4 KB
Accession
0001209191-23-007575
Insider Transaction Report
Form 5
Schatzman Randall C
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-12-06$1.18/sh+2,500$2,954→ 7,859 total - Purchase
Common Stock
2022-06-06$1.64/sh+2,500$4,101→ 5,359 total
Footnotes (1)
- [F1]Shares acquired under the issuer's Employee Stock Purchase Plan.
Documents
Issuer
Bolt Biotherapeutics, Inc.
CIK 0001641281
Entity typeother
Related Parties
1- filerCIK 0001604763
Filing Metadata
- Form type
- 5
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:53 PM ET
- Size
- 6.4 KB